{"article_title": "Drugmakers Raise Prices Despite Criticisms", "article_keywords": ["criticisms", "prescription", "raise", "power", "price", "uspfizer", "start", "increases", "plc", "pricing", "despite", "prices", "raised", "drugmakers"], "article_url": "http://www.wsj.com/articles/drugmakers-raise-prices-despite-criticisms-1452474210", "article_text": "Drugmakers didn\u2019t let up on price increases with the start of a new year, demonstrating the industry\u2019s pricing power in the face of mounting criticisms of prescription costs in the U.S.\n\nPfizer Inc., Amgen Inc., Allergan PLC, Horizon Pharma PLC and others have raised U.S. prices for dozens of branded drugs since late December, with many of the increases between 9% and 10%, according to equity analysts. The increases are on list...", "article_metadata": {"article.template": "snippet", "article.created": "2016-01-11T01:03:00.000Z", "article.section": "Business", "page.region": "na,us", "page.content.type": "Article", "twitter": {"domain": "wsj.com", "description": "Politicians, health care payers, doctors and patients criticized drug pricing in recent months, but that hasn\u2019t stopped pharmaceutical companies from continuing to jack up price tags.", "title": "Drugmakers Raise Prices Despite Criticisms", "image": {"src": "https://si.wsj.net/public/resources/images/BN-LJ538_1120pf_G_20151120134115.jpg", "alt": "Drugmakers keep raising prices despite mounting criticisms", "identifier": "https://si.wsj.net/public/resources/images/BN-LJ538_1120pf_D_20151120134115.jpg"}, "creator": "@Loftus", "site": "@WSJ", "card": "summary_large_image"}, "al": {"ios": {"url": "wsj://launch?articleid=SB10394930922060873346404581466910669462264&headline=Drugmakers%20keep%20raising%20prices%20despite%20mounting%20criticisms&weburl=http://www.wsj.com/articles/SB10394930922060873346404581466910669462264"}}, "page.site.product": "WSJ", "keywords": "Amgen,AMGN,Horizon Pharma,HZNP,Pfizer,PFE,Vanda Pharmaceuticals,VNDA,Allergan,AGN,marketing,markets,pricing,corporate,industrial news,political,general news,health,biotechnology,pharmaceuticals,medical equipment,supplies,financial investments,health care,life sciences,biopharmaceuticals,specialized drugs,medications,financial services,generic drugs,investing,securities,anti-inflammatory agents,medical,surgical instruments,apparatus,devices,therapeutic devices,equipment", "news_keywords": "Amgen,AMGN,Horizon Pharma,HZNP,Pfizer,PFE,Vanda Pharmaceuticals,VNDA,Allergan,AGN", "article.headline": "Drugmakers keep raising prices despite mounting criticisms", "cXenseParse": {"candybar": {"image": "https://si.wsj.net/public/resources/images/BN-LJ538_1120pf_E_20151120134115.jpg"}, "poptart": {"image": "https://si.wsj.net/public/resources/images/BN-LJ538_1120pf_D_20151120134115.jpg"}}, "description": "Politicians, health care payers, doctors and patients criticized drug pricing in recent months, but that hasn\u2019t stopped pharmaceutical companies from continuing to jack up price tags.", "apple-itunes-app": "app-id=364387007,app-argument=wsj://launch?articleid=SB10394930922060873346404581466910669462264&headline=Drugmakers%20keep%20raising%20prices%20despite%20mounting%20criticisms&weburl=http://www.wsj.com/articles/SB10394930922060873346404581466910669462264", "user.type": "nonsubscriber", "testkeys": "C", "article.page": "Health Care", "article.summary": "Politicians, health care payers, doctors and patients criticized drug pricing in recent months, but that hasn\u2019t stopped pharmaceutical companies from continuing to jack up price tags.", "page.site": "wsj", "page.content.format": "responsive", "article.published": "2016-01-11T01:03:00.000Z", "dj.asn": "i-4bd4", "robots": "noarchive,noodp", "fb": {"app_id": 368513495882}, "article": {"internal_link_count": 2, "image_count": 1, "word_count": 1016, "publisher": "https://www.facebook.com/wsj"}, "viewport": "width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no", "page.section": "Article", "language": "en-US", "og": {"site_name": "WSJ", "description": "Politicians, health care payers, doctors and patients criticized drug pricing in recent months, but that hasn\u2019t stopped pharmaceutical companies from continuing to jack up price tags.", "title": "Drugmakers Raise Prices Despite Criticisms", "url": "http://www.wsj.com/articles/drugmakers-raise-prices-despite-criticisms-1452474210", "image": {"width": 553, "identifier": "https://si.wsj.net/public/resources/images/BN-LJ538_1120pf_G_20151120134115.jpg", "height": 369}, "locale": "en_US", "type": "article"}, "author": "Peter Loftus", "article.access": "paid", "page.content.source": "WSJ Online Article", "article.origheadline": "Drugmakers Raise Prices Despite Criticisms", "article.type": "Health", "article.id": "SB10394930922060873346404581466910669462264", "user.exp": "default", "article.updated": "2016-01-11T01:03:00.000Z"}, "article_summary": "The increases are on list...\nDrugmakers didn\u2019t let up on price increases with the start of a new year, demonstrating the industry\u2019s pricing power in the face of mounting criticisms of prescription costs in the U.S.Pfizer Inc., Amgen Inc., Allergan PLC, Horizon Pharma PLC and others have raised U.S. prices for dozens of branded drugs since late December, with many of the increases between 9% and 10%, according to equity analysts."}